000 | 01522 a2200433 4500 | ||
---|---|---|---|
005 | 20250516123520.0 | ||
264 | 0 | _c20131017 | |
008 | 201310s 0 0 eng d | ||
022 | _a1755-5949 | ||
024 | 7 |
_a10.1111/cns.12036 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSonali, Nirmal | |
245 | 0 | 0 |
_aClinical effectiveness of rivastigmine monotherapy and combination therapy in Alzheimer's patients. _h[electronic resource] |
260 |
_bCNS neuroscience & therapeutics _cFeb 2013 |
||
300 |
_a91-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
650 | 0 | 4 |
_aCholinesterase Inhibitors _xadministration & dosage |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGene Frequency _xgenetics |
650 | 0 | 4 |
_aGlucuronosyltransferase _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMemantine _xadministration & dosage |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPharmacogenetics _xmethods |
650 | 0 | 4 |
_aPhenylcarbamates _xadministration & dosage |
650 | 0 | 4 | _aRivastigmine |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aTripathi, Manjari | |
700 | 1 | _aSagar, Rajesh | |
700 | 1 | _aVelpandian, Thirumurthy | |
700 | 1 | _aSubbiah, Vivekanandhan | |
773 | 0 |
_tCNS neuroscience & therapeutics _gvol. 19 _gno. 2 _gp. 91-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/cns.12036 _zAvailable from publisher's website |
999 |
_c22314345 _d22314345 |